Jeffrey Tate - 28 Apr 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Issuer symbol
CYTH
Transactions as of
28 Apr 2022
Transactions value $
$5,279
Form type
4
Date filed
29 Apr 2022, 15:36
Previous filing
02 Mar 2022
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $1.59K +635 +2.34% $2.50 27.8K 28 Apr 2022 Direct
transaction CYTH Common Stock Purchase $810 +300 +1.08% $2.70 28.1K 29 Apr 2022 Direct
transaction CYTH Common Stock Purchase $2.88K +1.07K +3.79% $2.71 29.2K 29 Apr 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.